Determinants of high-sensitivity troponin t among patients with a noncardiac cause of chest pain

Standard

Determinants of high-sensitivity troponin t among patients with a noncardiac cause of chest pain. / Irfan, Affan; Twerenbold, Raphael; Reiter, Miriam; Reichlin, Tobias; Stelzig, Claudia; Freese, Michael; Haaf, Philip; Hochholzer, Willibald; Steuer, Stephan; Bassetti, Stefano; Zellweger, Christa; Freidank, Heike; Peter, Federico; Campodarve, Isabel; Meune, Christophe; Mueller, Christian.

in: AM J MED, Jahrgang 125, Nr. 5, 05.2012, S. 491-498.e1.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

Irfan, A, Twerenbold, R, Reiter, M, Reichlin, T, Stelzig, C, Freese, M, Haaf, P, Hochholzer, W, Steuer, S, Bassetti, S, Zellweger, C, Freidank, H, Peter, F, Campodarve, I, Meune, C & Mueller, C 2012, 'Determinants of high-sensitivity troponin t among patients with a noncardiac cause of chest pain', AM J MED, Jg. 125, Nr. 5, S. 491-498.e1. https://doi.org/10.1016/j.amjmed.2011.10.031

APA

Irfan, A., Twerenbold, R., Reiter, M., Reichlin, T., Stelzig, C., Freese, M., Haaf, P., Hochholzer, W., Steuer, S., Bassetti, S., Zellweger, C., Freidank, H., Peter, F., Campodarve, I., Meune, C., & Mueller, C. (2012). Determinants of high-sensitivity troponin t among patients with a noncardiac cause of chest pain. AM J MED, 125(5), 491-498.e1. https://doi.org/10.1016/j.amjmed.2011.10.031

Vancouver

Bibtex

@article{5ea9982f4b0542d999a556c7c396caea,
title = "Determinants of high-sensitivity troponin t among patients with a noncardiac cause of chest pain",
abstract = "Background: It is unknown to what extent noncardiac causes, including renal dysfunction, may contribute to high-sensitivity cardiac troponin T levels. Methods: In an observational international multicenter study, we enrolled consecutive patients presenting with acute chest pain to the emergency department. Of 1181 patients enrolled, 572 were adjudicated by 2 independent cardiologists to have a noncardiac cause of chest pain. Multiple linear regression analyses were used to determine the important predictors of log-transformed high-sensitivity cardiac troponin T. Kaplan-Meier curve was used to assess the prognostic significance of high-sensitivity cardiac troponin T > 0.014 μg/L (99th percentile). Results: A total of 88 patients (15%) had high-sensitivity cardiac troponin T > 0.014 μg/L. Less than 50% of cardiac troponins could be explained by known cardiac or noncardiac diseases. In decreasing order of importance, age, estimated glomerular filtration rate, hypertension, previous myocardial infarction, and chronic kidney disease (adjusted r 2 0.44) emerged as significant factors in linear regression analysis to predict high-sensitivity cardiac troponin T. High-sensitivity cardiac troponin T was best explained by a linear curve with age as ≤ 0.014 μg/L. Patients with high-sensitivity cardiac troponin T levels > 0.014 μg/L were at increased risk for all-cause mortality (hazard ratio 3.0; 95% confidence interval, 0.8-10.6; P =.02) during follow-up. Conclusion: Among the known covariates, age and not renal dysfunction is the most important determinant of high-sensitivity cardiac troponin T. Because known cardiac and noncardiac factors, including renal dysfunction, explain less than 50% of high-sensitivity cardiac troponin T levels among patients with a noncardiac cause of chest pain, unknown or underestimated cardiac involvement during the acute presenting condition seems to be the major cause of elevated high-sensitivity cardiac troponin T.",
keywords = "Age, Chest pain, High-sensitivity cardiac troponin, Noncardiac, Renal dysfunction",
author = "Affan Irfan and Raphael Twerenbold and Miriam Reiter and Tobias Reichlin and Claudia Stelzig and Michael Freese and Philip Haaf and Willibald Hochholzer and Stephan Steuer and Stefano Bassetti and Christa Zellweger and Heike Freidank and Federico Peter and Isabel Campodarve and Christophe Meune and Christian Mueller",
note = "Funding Information: Funding: This study has been supported by research grants from the Swiss National Science Foundation , The Swiss Heart Foundation , the University Hospital Basel , Roche Diagnostics , and Siemens AG . ",
year = "2012",
month = may,
doi = "10.1016/j.amjmed.2011.10.031",
language = "English",
volume = "125",
pages = "491--498.e1",
journal = "AM J MED",
issn = "0002-9343",
publisher = "Elsevier Inc.",
number = "5",

}

RIS

TY - JOUR

T1 - Determinants of high-sensitivity troponin t among patients with a noncardiac cause of chest pain

AU - Irfan, Affan

AU - Twerenbold, Raphael

AU - Reiter, Miriam

AU - Reichlin, Tobias

AU - Stelzig, Claudia

AU - Freese, Michael

AU - Haaf, Philip

AU - Hochholzer, Willibald

AU - Steuer, Stephan

AU - Bassetti, Stefano

AU - Zellweger, Christa

AU - Freidank, Heike

AU - Peter, Federico

AU - Campodarve, Isabel

AU - Meune, Christophe

AU - Mueller, Christian

N1 - Funding Information: Funding: This study has been supported by research grants from the Swiss National Science Foundation , The Swiss Heart Foundation , the University Hospital Basel , Roche Diagnostics , and Siemens AG .

PY - 2012/5

Y1 - 2012/5

N2 - Background: It is unknown to what extent noncardiac causes, including renal dysfunction, may contribute to high-sensitivity cardiac troponin T levels. Methods: In an observational international multicenter study, we enrolled consecutive patients presenting with acute chest pain to the emergency department. Of 1181 patients enrolled, 572 were adjudicated by 2 independent cardiologists to have a noncardiac cause of chest pain. Multiple linear regression analyses were used to determine the important predictors of log-transformed high-sensitivity cardiac troponin T. Kaplan-Meier curve was used to assess the prognostic significance of high-sensitivity cardiac troponin T > 0.014 μg/L (99th percentile). Results: A total of 88 patients (15%) had high-sensitivity cardiac troponin T > 0.014 μg/L. Less than 50% of cardiac troponins could be explained by known cardiac or noncardiac diseases. In decreasing order of importance, age, estimated glomerular filtration rate, hypertension, previous myocardial infarction, and chronic kidney disease (adjusted r 2 0.44) emerged as significant factors in linear regression analysis to predict high-sensitivity cardiac troponin T. High-sensitivity cardiac troponin T was best explained by a linear curve with age as ≤ 0.014 μg/L. Patients with high-sensitivity cardiac troponin T levels > 0.014 μg/L were at increased risk for all-cause mortality (hazard ratio 3.0; 95% confidence interval, 0.8-10.6; P =.02) during follow-up. Conclusion: Among the known covariates, age and not renal dysfunction is the most important determinant of high-sensitivity cardiac troponin T. Because known cardiac and noncardiac factors, including renal dysfunction, explain less than 50% of high-sensitivity cardiac troponin T levels among patients with a noncardiac cause of chest pain, unknown or underestimated cardiac involvement during the acute presenting condition seems to be the major cause of elevated high-sensitivity cardiac troponin T.

AB - Background: It is unknown to what extent noncardiac causes, including renal dysfunction, may contribute to high-sensitivity cardiac troponin T levels. Methods: In an observational international multicenter study, we enrolled consecutive patients presenting with acute chest pain to the emergency department. Of 1181 patients enrolled, 572 were adjudicated by 2 independent cardiologists to have a noncardiac cause of chest pain. Multiple linear regression analyses were used to determine the important predictors of log-transformed high-sensitivity cardiac troponin T. Kaplan-Meier curve was used to assess the prognostic significance of high-sensitivity cardiac troponin T > 0.014 μg/L (99th percentile). Results: A total of 88 patients (15%) had high-sensitivity cardiac troponin T > 0.014 μg/L. Less than 50% of cardiac troponins could be explained by known cardiac or noncardiac diseases. In decreasing order of importance, age, estimated glomerular filtration rate, hypertension, previous myocardial infarction, and chronic kidney disease (adjusted r 2 0.44) emerged as significant factors in linear regression analysis to predict high-sensitivity cardiac troponin T. High-sensitivity cardiac troponin T was best explained by a linear curve with age as ≤ 0.014 μg/L. Patients with high-sensitivity cardiac troponin T levels > 0.014 μg/L were at increased risk for all-cause mortality (hazard ratio 3.0; 95% confidence interval, 0.8-10.6; P =.02) during follow-up. Conclusion: Among the known covariates, age and not renal dysfunction is the most important determinant of high-sensitivity cardiac troponin T. Because known cardiac and noncardiac factors, including renal dysfunction, explain less than 50% of high-sensitivity cardiac troponin T levels among patients with a noncardiac cause of chest pain, unknown or underestimated cardiac involvement during the acute presenting condition seems to be the major cause of elevated high-sensitivity cardiac troponin T.

KW - Age

KW - Chest pain

KW - High-sensitivity cardiac troponin

KW - Noncardiac

KW - Renal dysfunction

UR - http://www.scopus.com/inward/record.url?scp=84859517418&partnerID=8YFLogxK

U2 - 10.1016/j.amjmed.2011.10.031

DO - 10.1016/j.amjmed.2011.10.031

M3 - SCORING: Journal article

C2 - 22482847

AN - SCOPUS:84859517418

VL - 125

SP - 491-498.e1

JO - AM J MED

JF - AM J MED

SN - 0002-9343

IS - 5

ER -